CompletedNot Applicable

Fusion Versus Cognitive MRI Targeted Prostatic Biopsy

Egypt130 participantsStarted 2023-01-01

Plain-language summary

The aim of the present study is to compare the accuracy of Magnetic resonance imaging targeted (fusion) versus cognitive prostatic biopsy in biopsy-naïve suspected cancer prostate patient

Who can participate

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * prostate biopsy-naïve men * PSA levels of up to 20 ng/mL * Multi-parametric prostate MRI revealed a PIRAD 4 or PIRAD 5. Exclusion Criteria: * PSA level greater than 20 ng/mL * patient with history of TRUS biopsy * patient diagnosed as cancer prostate or with distant metastasis

What they're measuring

detection of clinically significant prostate cancer

Timeframe: two weeks

Trial details

NCT IDNCT05969704

SponsorMenoufia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Prostatic Cancer trials